Stockscreener 앱 받기
80.90
0.46%
-0.37
시장 영업 전:
80.91
0.010
+0.01%
Edwards Lifesciences Corp 주식(EW)의 최신 뉴스
Can Edwards Lifesciences Corporation stock recover from recent declineMarket Risk Report & Reliable Volume Spike Alerts - Newser
Analyzing recovery setups for Edwards Lifesciences Corporation investorsJuly 2025 Short Interest & AI Powered Buy and Sell Recommendations - Newser
Applying big data sentiment scoring on Edwards Lifesciences CorporationPortfolio Gains Report & Safe Entry Zone Identification - Newser
Edwards Lifesciences Corporation stock trendline breakdown2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
Should you wait for a breakout in Edwards Lifesciences CorporationQuarterly Market Summary & Safe Capital Growth Trade Ideas - Newser
Intraday pattern recognizer results for Edwards Lifesciences Corporation2025 Top Gainers & High Accuracy Swing Trade Signals - Newser
Moving Average Crossover Confirms Uptrend in Edwards Lifesciences Corporation getLinesFromResByArray error: size == 0 - kangso.co.kr
Edwards Lifesciences Corporation stock daily chart insightsInsider Buying & Short-Term High Return Ideas - Newser
What Fibonacci levels say about Edwards Lifesciences Corporation reboundJuly 2025 Gainers & Pattern Based Trade Signal System - Newser
Key resistance and support levels for Edwards Lifesciences CorporationLong Setup & Expert Verified Movement Alerts - Newser
Insider Action: Major Stock Sale at Edwards Lifesciences! - TipRanks
Price action breakdown for Edwards Lifesciences CorporationIndex Update & Low Volatility Stock Recommendations - Newser
Using flow based indicators on Edwards Lifesciences CorporationTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Edwards Lifesciences Corp announces CVP Chopra Daveen sells 2,500 shares at $81.95 on 2023-08-25. - AInvest
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors - MarketWatch
Pulnovo Medical appoints Edwards Lifesciences veteran as CMO - Investing.com
Pulnovo Medical appoints Edwards Lifesciences veteran as CMO By Investing.com - Investing.com UK
TAVR Pioneer Behind $4B Edwards Program: Dr. Francis Duhay Joins Pulnovo Medical as Global CMO - Stock Titan
Using R and stats models for Edwards Lifesciences Corporation forecastingJuly 2025 Setups & Detailed Earnings Play Alerts - Newser
Edwards Lifesciences’ TRISCEND II Trial: A Game-Changer in Tricuspid Valve Treatment? - MSN
Edwards Lifesciences Corporation Price Holds Above Key Fib Level2025 Geopolitical Influence & Real-Time Volume Triggers - beatles.ru
Edwards Lifesciences Corp: A Leader in Medical Devices with Strong Financial Stance and Competitive Strengths - AInvest
Edwards Lifesciences: A Market Leader Stuck In 'Hold' Mode Despite Solid Growth (NYSE:EW) - Seeking Alpha
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Leerink Partners raises Edwards Lifesciences stock price target on share buyback - Investing.com
Leerink Partners Adjusts PT on Edwards Lifesciences to $85 From $84, Maintains Market Perform Rating - MarketScreener
Edwards Lifesciences Corporation (EW) Announces Accelerated Shar - GuruFocus
Edwards Lifesciences Reports $500 Million Accelerated Share Buyback - MarketScreener
Edwards Lifesciences announces $500 million accelerated share repurchase - Investing.com
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase - MarketScreener
Achieve Life Sciences, Inc. shares fall 2.44% intraday amid FTC's challenge to Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc. - AInvest
Achieve Life Sciences shares rise 2.26% premarket after FTC challenges Edwards Lifesciences Corp.'s acquisition of JenaValve Technology, Inc. - AInvest
Edwards Lifesciences exec Wood sells $698k in shares - Investing.com
FTC Sues to Block Edwards LifeSciences Medical Device Deal - MSN
Stock Analysis | Edwards Lifesciences OutlookNavigating Mixed Signals in a Volatile Landscape - AInvest
Edwards Lifesciences Hits $0.2B Trade Volume Amid Trial Progress Ranks 479th in Daily Activity - AInvest
Edwards Lifesciences’ ENCIRCLE Trial: A New Hope for Mitral Regurgitation Patients - TipRanks
Edwards Lifesciences’ TRISCEND Study: A Game-Changer in Tricuspid Valve Replacement? - TipRanks
FTC Moves to Block Edwards Lifesciences’ $945 Million Acquisition of JenaValve Over Competition Concerns - MSN
FTC to block Edwards Lifesciences’ acquisition of JenaValve due to competitive concerns - Yahoo Finance
FTC seeks to block Edwards Lifesciences' acquisition of JenaValve - MSN
Edwards Lifesciences Rebounds on Institutional Buys Despite Securities Probe as $220M Volume Ranks Among Top 500 - AInvest
Edwards Lifesciences Advances with SAPIEN X4 Heart Valve Study - TipRanks
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Edwards Lifesciences Rises 0.97% Amid 427th-Ranked Trading Volume as Fundamentals and Technicals Clash - AInvest
Moody’s revises Edwards Lifesciences outlook to positive, affirms Baa2 - Investing.com
Moody’s revises Edwards Lifesciences outlook to positive, affirms Baa2 By Investing.com - Investing.com Canada
Edwards Lifesciences Stock: Analyst Estimates & Ratings - Barchart.com
0.23%
0.43%
자본화:
|
볼륨(24시간):